Stage-specific inhibition of Xenopus embryogenesis by aprotinin, a serine protease inhibitor

J Biochem. 1999 Nov;126(5):912-6. doi: 10.1093/oxfordjournals.jbchem.a022534.

Abstract

We examined the effects of various protease inhibitors on Xenopus laevis embryogenesis. Aprotinin, a serine protease inhibitor, was found to inhibit embryogenesis markedly, but other protease inhibitors had virtually no effect. The inhibitory effect of aprotinin was specific for embryos at the blastula or gastrula stage. These results suggest that an aprotinin-sensitive protease involved in embryonic development is secreted from the embryos or appears on the surface of embryonic cells at these stages. We found that various serine proteases are in fact secreted from the embryos with their development and that some of them are sensitive to aprotinin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Aprotinin / pharmacology*
  • Blastocyst / drug effects
  • Culture Media
  • Embryonic and Fetal Development / drug effects*
  • Embryonic and Fetal Development / physiology
  • Endopeptidases / metabolism
  • Gastrula / drug effects
  • Oligopeptides / chemistry
  • Protease Inhibitors / pharmacology
  • Serine Endopeptidases / physiology
  • Serine Proteinase Inhibitors / pharmacology*
  • Substrate Specificity
  • Time Factors
  • Xenopus laevis / embryology*
  • Xenopus laevis / physiology

Substances

  • Culture Media
  • Oligopeptides
  • Protease Inhibitors
  • Serine Proteinase Inhibitors
  • Aprotinin
  • Endopeptidases
  • Serine Endopeptidases